Diana Quelhas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Diana Quelhas has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Brittney Wittenbrink
Nutrition Innovation, PATH, 2201 Westlake Avenue, Suite 200, Seattle, WA, 98121, USA
1 shared publication - Chytanya Kompala
Nutrition Innovation, PATH, 2201 Westlake Avenue, Suite 200, Seattle, WA, 98121, USA
1 shared publication - Jessica Fanzo
The School of Advanced International Studies Johns Hopkins University Bologna Italy
1 shared publication - Katharine Kreis
Nutrition Innovation, PATH, 2201 Westlake Avenue, Suite 200, Seattle, WA, 98121, USA
1 shared publication - Klaus Kraemer
University of Graz, Graz
1 shared publication - Megan Parker
PATH, Seattle, Washington, United States of America
1 shared publication
Latest Publications
- Open Access
- 13 December 2018
- Published by Springer Nature in BMC Public Health
- Vol. 18 (1) , 1-17
The association between active tobacco use during pregnancy and growth outcomes of children under five years of age: a systematic review and meta-analysis
Despite considerable global efforts to reduce growth faltering in early childhood, rates of stunting remain high in many regions of the world. Current interventions primarily target nutrition-specific risk factors, but these have proven insufficient. The objective of this study was to synthesize the evidence on the relationship between active tobacco use during pregnancy and growth outcomes in children under five years of age. In this systematic review and meta-analysis, six online databases were searched to identify studies published from January 1, 1980, through October 31, 2016, examining the association between active tobacco use during pregnancy and small-for-gestational age (SGA), length/height, and/or head circumference. Ecological studies were not included. A meta-analysis was conducted, and subgroup analyses were carried out to explore the effect of tobacco dosage. Among 13,189 studies identified, 210 were eligible for inclusion in the systematic review, and 124 in the meta-analysis. Active tobacco use during pregnancy was associated with significantly higher rates of SGA (pooled adjusted odds ratio [AORs] = 1.95; 95% confidence interval [CI]: 1.76, 2.16), shorter length (pooled weighted mean difference [WMD] = 0.43; 95% CI: 0.41, 0.44), and smaller head circumference (pooled WMD = 0.27; 95% CI: 0.25, 0.29) at birth. In addition, a dose-response effect was evident for all growth outcomes. Tobacco use during pregnancy may represent a major preventable cause of impaired child growth and development.
- 13 December 2018
- Published by Springer Nature in BMC Public Health
- Vol. 18 (1) , 1-17
Open AccessThe association between active tobacco use during pregnancy and growth outcomes of children under five years of age: a systematic review and meta-analysis
Despite considerable global efforts to reduce growth faltering in early childhood, rates of stunting remain high in many regions of the world. Current interventions primarily target nutrition-specific risk factors, but these have proven insufficient. The objective of this study was to synthesize the evidence on the relationship between active tobacco use during pregnancy and growth outcomes in children under five years of age. In this systematic review and meta-analysis, six online databases were searched to identify studies published from January 1, 1980, through October 31, 2016, examining the association between active tobacco use during pregnancy and small-for-gestational age (SGA), length/height, and/or head circumference. Ecological studies were not included. A meta-analysis was conducted, and subgroup analyses were carried out to explore the effect of tobacco dosage. Among 13,189 studies identified, 210 were eligible for inclusion in the systematic review, and 124 in the meta-analysis. Active tobacco use during pregnancy was associated with significantly higher rates of SGA (pooled adjusted odds ratio [AORs] = 1.95; 95% confidence interval [CI]: 1.76, 2.16), shorter length (pooled weighted mean difference [WMD] = 0.43; 95% CI: 0.41, 0.44), and smaller head circumference (pooled WMD = 0.27; 95% CI: 0.25, 0.29) at birth. In addition, a dose-response effect was evident for all growth outcomes. Tobacco use during pregnancy may represent a major preventable cause of impaired child growth and development.